Daria Mochly-Rosen Explained

Daria Mochly-Rosen is a Professor of Chemical and Systems Biology at the Stanford University School of Medicine, where she also holds the George D. Smith Chair for Translational Medicine.[1] She is in addition the founder of Mitoconix Bio, a startup company whose goal is to produce drugs that treat Huntington's disease and other neurodegenerative illnesses.[2] [3] [4]

Notes and References

  1. Web site: Daria Mochly-Rosen . . 2018-08-12.
  2. Web site: Neurological therapy co Mitoconix Bio raises $20m . Globes . 2017-06-27.
  3. Web site: California Life Sciences Association (CLSA) Adds Leaders from City of Hope, Stanford to Board of Directors . 2017-02-13 .
  4. Web site: Israeli startup takes aim at Huntington's disease . . 2017-07-05 . Danney . Micah . 2018-08-12.

This article is licensed under the GNU Free Documentation License. It uses material from the Wikipedia article "Daria Mochly-Rosen".

Except where otherwise indicated, Everything.Explained.Today is © Copyright 2009-2024, A B Cryer, All Rights Reserved. Cookie policy.